Loading...
Market
Will the first GmPcide compound derived from PS757 be approved for clinical use by August 5, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA announcements and official press releases
Story
New Compound PS757 Fights Drug-Resistant Bacteria, Guides GmPcide Development
Aug 5, 2024, 07:05 AM
Researchers have discovered a new compound, PS757, that shows promise in fighting flesh-eating and other drug-resistant bacteria. This revolutionary dual-action antibiotic makes bacterial resistance nearly impossible by damaging the cell membranes of the bacteria. The findings, which were tested on Gram-positive pathogens in mice, are expected to guide the development and optimization of a new class of antibiotics called GmPcide compounds. The discovery was announced on August 4 and further detailed on August 5.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
